ArticleScientific reports2025
Redefine tumor spheroids heterogeneity via PCA-coupled biophysical characterization.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Three-dimensional spheroid models in breast cancer: tumor microenvironment complexity, cancer stem cell-driven resistance, and translational model integration.Journal of translational medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Spheroids, a part of 3D cell culture systems, are crucial models for bridging in-vitro and in-human studies. However, achieving reliable standardization remains difficult, even when comparing spheroids of similar diameters. The challenge arises due to their cross-sectional architecture, which increases heterogeneity and affects biological outcomes. Here we present a novel solution that integrates Principal Component Analysis (PCA) and Hierarchical Cluster Analysis (HCA) with Biophysical Characterization (PCA-BC). This approach allows for the identification and classification of variability within and across spheroid populations, offering insights into factors that contribute to heterogeneity. Additionally, it highlights the impact of different operators on spheroid development. The PCA-BC method enables real-time analysis of spheroid samples, facilitating the identification of variability across 3D populations. The integration of PCA and HCA with biophysical characterization provides a clear and efficient means to monitor sample heterogeneity. It also helps track how different operators influence the results, improving overall standardization in 3D cell cultures. By offering structural insights into spheroid heterogeneity, the PCA-BC approach supports more informed decision-making. This significantly improves workflow efficiency, conserving both time and resources, and enhances the reliability of 3D cell culture experiments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.